Astellas
Astellas breaks ground on $95m antibody facility
January 20, 2011Manufacturing and Production Agensys, Astellas, antibodies, antibody
Astellas has broken ground on a $95 million R&D and manufacturing facility in Santa Monica, USA, that will also serve …
Working Life: Astellas Pharma Europe’s chief operating officer
January 4, 2011Business Services, Sales and Marketing Astellas, Ken Jones, Working Life, recruitment
Ken Jones tells Pharmafocus about how his field is changing, starting with how he found his way into his current …
Astellas signs stem cell partnership in liver disease
December 8, 2010Research and Development Astellas, Cytori, Stem cells, liver disease, regenerative medicine
Astellas has teamed up with Cytori Therapeutics to develop a range of new stem cell treatments for liver disease and …
Digital Pharma: Pharma iPhone app update
October 15, 2010Medical Communications Astellas, Boehringer, Digital Pharma blog, GlaxoSmithKline, Lundbeck, Menarini, Nycomed, Pfizer, Servier, Teva, app, iphone
The ranks of pharma iPhone apps are increasing all the time and recent months have seen new additions from Teva, …
Astellas taps into overactive bladder market with garden display
July 13, 2010Medical Communications Astellas, Vesicare, disease awareness campaigns, overactive bladder
Astellas has launched a campaign to raise awareness of overactive bladder with the help of an award winning garden designer …
Astellas Pharma censured over advisory boards
July 9, 2010Medical Communications, Sales and Marketing Astellas, Code of Practice, PMCPA
Astellas has been the subject of ‘naming and shaming’ advertisements in three medical journals after advisory board meetings it ran …
Astellas set to acquire OSI Pharmaceuticals for $4bn
May 17, 2010Research and Development, Sales and Marketing Astellas, M&A, MA, OSI
After four months and several failed bids Astellas Pharma has signed a definitive merger agreement with US biotech firm OSI …
Astellas eyes oncology growth
April 21, 2010Research and Development, Sales and Marketing Astellas, Astellas Pharma Europe
Astellas Pharma Europe has set its sights on the oncology market, earmarking the therapy area as its latest “franchise focus” …
OSI resists Astellas and invites other offers
March 16, 2010Sales and Marketing Astellas, OSI, merger
A new takeover bid launched by Japanese pharma company Astellas for OSI Pharma has been rejected by the company’s board. …
Astellas moves in on OSI Pharmaceuticals
March 2, 2010Sales and Marketing Astellas, Astellas Pharma Europe, OSI
Astellas has launched a hostile takeover bid for OSI Pharmaceuticals, going directly to stockholders with a proposal that values the US …
Astellas signs European deal in pain management
June 23, 2009Research and Development, Sales and Marketing Astellas
Astellas has struck a deal with Californian company NeurogesX to market in Europe a treatment for pain linked to peripheral …
CV Therapeutics rejects Astellas takeover bid
February 23, 2009Sales and Marketing Astellas, CV Therapeutics
Biotech company CV Therapeutics has rejected a second take-over offer from Astellas, saying the Japanese group failed to recognise its …
Germany loses out in Astellas restructuring
August 2, 2007Sales and Marketing Astellas, Germany
Astellas has announced streamlining and cutbacks to its operations across Europe, with operations in Germany losing staff in its saleforce …
Latest content
FibroFind appoints Lee Borthwick as CEO
